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Severe Acute Respiratory Syndrome (SARS) is caused by a novel coronavirus (SARS-CoV). Coronaviruses including SARS-CoVencode
an envelope (E) protein, a small, hydrophobic membrane protein. We report that, in planar lipid bilayers, synthetic peptides corresponding to
the SARS-CoV E protein forms ion channels that are more permeable to monovalent cations than to monovalent anions. Affinity-purified
polyclonal antibodies recognizing the N-terminal 19 residues of SARS-CoV E protein were used to establish the specificity of channel
formation by inhibiting the ion currents generated in the presence of the E protein peptides.
D 2004 Elsevier Inc. All rights reserved.
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Mouse hepatitis virus (MHV)Introduction
Severe Acute Respiratory Syndrome (SARS) is a
respiratory illness that has recently been reported in Asia,
North America, and Europe (Drosten et al., 2003; Ksiazek
et al., 2003; Peiris et al., 2003). The World Health
Organization (WHO) reported that the cumulative number
of probable cases of SARS between 16 November 2002
and 7 August 2003 was 8422 with 916 deaths, just over a
10% death rate (World Health Organization, 2003).
Coronaviruses [Order Nidovirales, family Coronaviridae,
Genus Coronavirus (Gonzalez et al., 2003)] are enveloped,
positive-stranded RNA viruses that bud from the endo-
plasmic reticulum–Golgi intermediate compartment or the
cis-Golgi network (Klumperman et al., 1994; Krijnse-
Locker et al., 1994; Tooze et al., 1984). The coronavirus
envelope characteristically contains two major viral struc-
tural proteins, the spike (S) glycoprotein (for review, see0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: lwilson@biotron.com.au (L. Wilson).Gallagher and Buchmeier, 2001) and the membrane (M)
glycoprotein. A third minor but important membrane
protein is the envelope (E) protein (Siddell, 1995a). E
protein is a small, 9–12 kDa integral membrane protein
(Siddell, 1995b). The N-terminus consists of a short 7–9
amino acid hydrophilic region and a 21–29 amino acid
hydrophobic region, followed by a hydrophilic C-terminal
region (Shen et al., 2003). E proteins play a part in viral
assembly and morphogenesis. Co-expression of E and M
proteins, from mouse hepatitis virus (MHV) (Bos et al.,
1996; Vennema et al., 1996), transmittable gastroenteritis
virus (TGEV), Bovine coronavirus (BCoV) (Baudoux et
al., 1998), infectious bronchitis virus (IBV) (Corse and
Machamer, 2000), and SARS-CoV (Ho et al., 2004) results
in nucleocapsid independent formation of virus-like par-
ticles (VLPs). Additionally, MHV and IBV E protein
expressed alone results in assembly of E-protein-containing
vesicles, with a density similar to that of VLPs (Corse and
Machamer, 2000; Maeda et al., 1999). Further evidence of
E protein’s important role in virus assembly and morpho-
genesis is that MHV E gene mutants have aberrant
morphology with pinched and elongated shapes (Fischer
et al., 1998). Recently, MHV recombinant virus was04) 322–331
L. Wilson et al. / Virology 330 (2004) 322–331 323constructed with the entire E gene deleted. The virus was
able to replicate to low titer and had a small plaque
phenotype, indicating that E protein although important, is
not essential for MHV replication in vitro (Kuo and
Masters, 2003; Shen et al., 2003). In contrast, E protein
expression is essential for TGEV replication, as deletion of
the TGEV E protein is lethal and replication of the mutant
virus can be rescued by TGEV E protein expressed in trans
(Ortego et al., 2002).
Primarily due to their small size, and hydrophobic
nature, coronavirus E proteins are candidate members of a
family of virus-encoded proteins that form ion channels.
(Fischer and Sansom, 2002; Gonzalez and Carrasco, 2003).
These include influenza virus proteins, M2 (Duff and
Ashley, 1992; Duff et al., 1994; Pinto et al., 1992) BM2
(Mould et al., 2003) and NB (Sunstrom et al., 1996), HIV-
1 proteins, Vpu (Ewart et al., 1996), and Vpr (Piller et al.,
1996), the 6K protein of alphaviruses (Melton et al., 2002),
and, recently, the hepatitis C virus (HCV) protein, p7
(Griffin et al., 2003; Pavlovic et al., 2003; Premkumar et
al., 2004). Based on similarities to other virus ion
channels, we hypothesized that the SARS-CoV E protein
might form ion channels. In this paper, we demonstrate
that SARS-CoV E protein does form ion channels, which
are more selective for monovalent cations than monovalent
anions.Results
Peptide synthesis and purification
A synthetic 76-residue peptide, corresponding to the full-
length SARS-CoV E protein (isolate Tor2 and Urbani), was
prepared using solid phase chemistry as described in
Materials and methods. A second peptide was also
synthesized, corresponding to the N-terminal 40 amino
acids of the E protein and encompassing the hydrophobic
domain. These are referred to as bfull-length peptideQ and
bN-terminal peptideQ, respectively.
MALDI-TOF mass spectrometry of the synthetic pep-
tides revealed that, in addition to the expected products, the
crude preparations also contained molecules with lower
mass to charge (m/z) ratio, presumably corresponding to
truncated peptides generated during chemical synthesis
process. After purification to enrich the desired products—
as described in Materials and methods—the mass spectra
showed a predominant, well-isolated peak at m/z ratio of
8360.1 for the full-length peptide, corresponding to the
calculated molecular weight of the SARS E protein (Fig.
1A). Similarly, a prevalent peak at the expected m/z ratio of
4422.3 was seen in the purified preparations of the N-
terminal peptide (Fig. 1B). The spectra of the N-terminal
peptide indicated that the preparation was clean with respect
to low molecular weight contaminants; however, in contrast
to the full-length peptide, peaks of decreasing intensity arepresent, corresponding to products sequentially truncated by
single amino acid residues.
Ion channel formation in planar lipid bilayers
SARS-CoV E protein full-length and N-terminal pep-
tides were tested for their ability to form ion channels in
planar lipid bilayers. Initial experiments were done with
500 mM NaCl in the CIS chamber and 50 mM NaCl in the
TRANS chamber. Small aliquots of the peptides dissolved
in TFE were added to the CIS chamber while stirring to
facilitate collision between peptide and bilayer. Sponta-
neous insertion of ion channel forming peptides into
bilayers from TFE solution has been demonstrated
previously with a number of small hydrophobic peptides
(Ewart et al., 1996; Griffin et al., 2003; Melton et al.,
2002; Pavlovic et al., 2003; Premkumar et al., 2004;
Schubert et al., 1996b; Sunstrom et al., 1996). In general,
ion currents due to SARS-CoV E protein were observed
about 5–15 min after peptide was added to the CIS
chamber in over 60 experiments. Initiation of channel
activity was detected more rapidly and reliably when a
holding potential of approximately 100 mV was applied
across the bilayer, suggesting that peptide insertion into the
bilayer was facilitated by a negative potential (TRANS
relative to CIS).
Currents recorded at 88 mV and at 48 mV from a
representative experiment with full-length E protein are
shown in Fig. 2A, with all points histograms at each
potential shown in parts B and C, respectively. In this
experiment, the direction of current flow was observed to
reverse between +40 and +50 mV and using an interpolated
value of +48 mV the conductance was calculated to be 52
pS at 88 mV and 47 pS at 48 mV. Fig. 3A shows typical
current traces of full-length E protein ion channel, recorded
over a range of holding potentials, showing that the current–
voltage (IV) relationship is not linear with conductance
being relatively larger at more negative holding potentials
(Fig. 3B). If the IV curve is linear, the channel has a
constant conductance equal to the slope of the line. Some
channels have conductances that vary with voltage and the
IV is therefore nonlinear, the channel has larger current at
higher potentials. The currents we measure are normally
aggregated currents from a number of ion channels and the
current amplitude (I) is given by NPo  gamma(Vm  Vr),
where N is the total number of channels in the bilayer, Po is
the average open probability of these channels, gamma is
single channel conductance, Vm is the potential applied
across the bilayer membrane, and Vr is the potential at which
currents reverse direction. As seen with other ion channels,
it is not unlikely that Po may be potential-dependent and this
would give the nonlinear IV curves we see. Note, however,
that the reversal potential is not affected by the voltage
dependence of Po.
In seven separate experiments with NaCl solution (Table
1), the average reversal potential was +48.3 F 2.3 mV
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Fig. 1. SARS-CoV full-length and N-terminal E protein mass spectral analysis. Full-length E protein shows a predominant peak at m/z ratio of 8360.1, the
expected molecular weight. The N-terminal peptide shows a prevalent peak at 4422.3 m/z, peaks of decreasing intensity are present, corresponding to products
sequentially truncated by single amino acid residues.
L. Wilson et al. / Virology 330 (2004) 322–331324(mean F SEM), which is close to the theoretical Na+
equilibrium potential of +54 mV (using activities in the
Nernst equation). From this, it can be calculated that the ion
channels are about 90 times more permeable to Na+ ions than
to Cl ions. For these seven experiments, the maximum
conductance varied between 95 and 164 pS and the average
conductance was 130 F 13 pS.
The channel formed by the E protein also conducted
potassium ions, as shown in Fig. 3C over a range ofholding potentials. In the experiment shown in Fig. 3D,
with 500 mM KCl in the CIS chamber and 50 mM KCl in
the TRANS chamber, the currents reversed at +31 mV. In
four similar experiments, the average reversal potential
was +34.5 F 2.5 mV (Table 1) indicating that the SARS-
CoV E protein ion channel is about nine times more
permeable to K+ ions than to Cl ions (Table 1). In those
four experiments, the maximum conductance varied
between 24 and 166 pS and the average conductance
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Fig. 2. SARS-CoV E protein ion channel currents in lipid bilayers. The CIS chamber contained 500 mM NaCl, 5 mM HEPES buffer (pH 7.2); the TRANS
chamber contained 50 mM NaCl, 5 mM HEPES buffer (pH 7.2). (A) Sample traces of raw current data, filtered at 100 Hz. The closed state is shown as a
broken line, openings are deviations from the line. Scale bars are 200 ms and 5 pA. Potential was held at 88 or 48 mV. Conductances were 52 or 47 pS,
respectively. (B) All points histograms of currents shown in A at 88 and C at 48 mV.
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considerably less positive in KCl than in NaCl solution,
indicating that the channel is relatively less selective for
K+ than for Na+ ions.
The bN-terminal peptideQ—corresponding to the first
40 amino acids of the SARS-CoV E protein—formed
monovalent cation-selective channels with properties
similar to those of the full-length peptide. The mean
reversal potentials (Vr) for currents formed by the full-
length and N-terminal peptides measured in NaCl
solutions were not significantly different from each other
(see Table 1), nor were the Vr measured in KCl solutions
significantly different. However, for both peptides, com-
parison of the Vr measured in KCl with that measured in
NaCl solutions revealed a significant difference (P b
0.003). The ion selectivity series for both peptides was
Na+ N K+ N Cl with the channels being approximately
5–10 fold more permeable to Na+ than K+ and
approximately 10-fold more permeable to K+ than Cl.
Given the above similarities, we conclude that pore-
forming structure and selectivity filter for the SARS-CoV
E protein are encoded within the first 40 amino acids of
the N-terminal, as might be predicted from the hydro-
pathy profile of the E protein.
In 10 control experiments in which no protein was added
to the CIS chamber, no ion channel activity was detected,
even during observation periods lasting for over 1 h.
Therefore, channel formation was dependant on addition
of peptide samples and was not an artifact of the lipids,
buffers, or solvents alone.Inhibition of peptide ion channels by N-terminal
epitope-specific antibodies
As described above, mass spectral analysis established
the presence and predominance of the full-length peptide
(m/z ratio of 8360.1) in purified preparations. However,
less intense peaks were also present indicating presence of
minor contamination by smaller molecules not removed by
the purification steps. These were mainly apparent below
an m/z ratio of approximately 6000. Therefore, it was
important to show that channel formation was specific to
the full-length peptide and not the contaminants. To
achieve this, we synthesized a third peptide corresponding
to the first 19 N-terminal amino acids of the SARS E
protein and used it to raise and purify polyclonal antibodies
recognizing this domain (see Materials and methods).
Previous results with other ion-channel-forming proteins
have shown that such epitope-specific antibodies can inhibit
channel activity, or be used to selectively remove the
channel-forming species from preparations (Ewart et al.,
1996; Melton et al., 2002; Sunstrom et al., 1996).
When the purified antibody was used to probe Western
blots a ladder of four discrete immunoreactive bands was
seen in lanes in which either the purified full-length (Fig.
4A) or N-terminal peptide (Fig. 4B) had been run, indicating
that these peptides form aggregates. The aggregates were
not disrupted by addition of reducing agent, h-mercaptoe-
thanol, nor were they significantly affected by boiling or not
boiling the samples prior to PAGE (not shown). In the blot
shown in Fig. 4, relatively large quantities of peptide were
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Fig. 3. SARS-CoV E protein ion channel activity observed in NaCl or KCl solutions. Data filtered at 100 Hz. (A) The CIS chamber contained 500 mM NaCl,
5 mM HEPES buffer (pH 7.2); the TRANS chamber contained 50 mM NaCl, 5 mM HEPES buffer (pH 7.2). The CIS chamber was earthed and the TRANS
chamber was held at various potentials between 88 and +112 mV. The closed state is shown as a broken line, openings are deviations from the line. Scale bars
are 200 ms and 10 pA. (B) IV relationship in NaCl solution average current measured against holding potential (mV). (C) The CIS chamber contained 500 mM
KCl, 5 mM HEPES buffer (pH 7.2); the TRANS chamber contained 50 mM KCl in 5 mM HEPES buffer (pH 7.2). The CIS chamber was earthed and the
TRANS chamber was held at various potentials between 89 and +91 mV. The closed state is shown as a broken line, openings are deviations from the line.
Scale bars are 200 ms and 10 pA. (D) IV relationship in KCl solution, average current measured against holding potential (mV).
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monomeric peptide molecules) ran just above or below the
11 kDa marker for the full-length and N-terminal peptides,
respectively. The observation that these putative monomers
do not run at their theoretical molecular weights is not an
unusual phenomenon for small hydrophobic peptides, where
it is thought that the uniform binding of SDS may be
affected, altering the relative rate of migration through
polyacrylamide gels. For example, chemically cross-linkedTable 1
Reversal potentials (mV)
SARS E NaCl KCl
protein
Vr Gamma Vr Gamma
Full length 48.3 F 2.3
(n = 7)
130 F 13 pS 34.5 F 2.5
(n = 4)
83.4 F 26 pS
TM domain 46.3 F 2.5
(n = 7)
35 F 7 pS 39.5 F 3.6
(n = 5)
93 F 36 pShomo-oligomers of the HIV-1 protein Vpu do not run at
their calculated molecular weights (Maldarelli et al., 1993).
Importantly, the Western blots did not show any immuno-
reaction with lower molecular weight bands that might
correlate to truncated peptides or contaminating species. By
this criterion, the purified antibody was judged to be a
specific reagent for binding to the N-terminal epitope of
full-length and N-terminal peptides. Further, the anti-N-
terminal antibody did not cross-react with a nonspecific
protein antigen, such as the hepatitis C (HCV) p7 protein
(Fig. 4, lanes 3).
In bilayer experiments, addition of approximately three-
fold molar excess of affinity-purified antibody recognizing
the N-terminal domain of SARS-CoV E protein to the CIS
chamber significantly reduced (P z 0.005, n = 4 experi-
ments) the current amplitude in NaCl solution as illustrated
for one of the experiments in Fig. 5. In contrast, addition of
the antibody to the TRANS chamber did not affect ion
Fig. 4. SARS-CoV full-length E and N-terminal peptide Western blot. Lane
1: marker; lane 2: without h-mercaptoethanol; lane 3: Hepatitis C p7; lane 4:
with h-mercaptoethanol. (A) About 150 Ag/lane full-length E protein
detected with anti-N terminal polyclonal antibody. (B) About 30 Ag/lane E
proteinN-terminal peptide detectedwith anti-N terminal polyclonal antibody.
L. Wilson et al. / Virology 330 (2004) 322–331 327channel conductance (Fig. 5). In separate experiments (not
shown), the antibody did not affect ion channel conductance
due to HCV p7 in planar lipid bilayers.A
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Fig. 5. SARS-CoV E protein ion channel activity is blocked by anti-N-terminal aff
mMHEPES buffer (pH 7.2); the TRANS chamber contained 50mMNaCl, 5mMHE
mV. The closed state is shown as a broken line, openings are deviations from the li
addition of antibody. (B) E protein ion channel activity after addition of V20 Ag ant
activity before addition of antibody. (D) E protein ion channel activity after additioTaken together, antibody-specific inhibition of the ion
conductances in planar lipid bilayers in an orientation-
dependant manner (as shown in Fig. 5), and lack of
detectable immunoreaction of the antibodies with low
molecular weight species on Western blots confirms that
ion channel formation in these experiments is due to
peptides containing the SARS-CoV E protein N-terminal
sequence and is not an artifact due to significantly truncated
peptides or other contaminating molecules.Discussion
We have shown that synthetic peptides corresponding to
the full-length SARS-CoV E protein and its N-terminal
domain form cation-selective ion channels in planar lipid
bilayers. Affinity-purified polyclonal antibodies to the N-
terminal domain of the SARS-CoV E protein specifically
block the ion channel activity, supporting our conclusion
that the ion channel activity is due to the SARS-CoV E
protein and not to minor contaminants in the preparations.
Addition of the anti-N-terminal antibody to the CIS
chamber reduced average bilayer current generated by the
SARS-CoV E protein by 73% F 16 (1 SEM), whereas
addition of the anti-N-terminal antibody to the TRANS
chamber did not significantly reduce conductance. As well
as confirming specificity, this result indicates that the N-
terminus faces into the CIS chamber. With the exception ofC
D
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chamber
inity-purified polyclonal antibody. CIS chamber contained 500 mM NaCl, 5
PESbuffer (pH 7.2). Representative current traces at holding potential of60
ne. Scale bars are 0.15 s and 2 pA. (A) E protein ion channel activity before
i-N-terminal antibody to the CIS chamber (n = 4). (C) E protein ion channel
n of V20 Ag anti-N-terminal antibody to the TRANS chamber (n = 4).
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the bilayer once, as a single alpha helix, so it is tempting to
assume that the C-terminus would be located in the TRANS
chamber. However, very recently, evidence was presented
that the SARS-CoV E protein transmembrane domain can
form a palindromic transmembrane helical hairpin and
incorporation of the helical hairpin into lipid vesicles
increased membrane curvature by deforming lipid bilayers
(Arbely et al., 2004), a known function of viral ion channel
family proteins (Gonzalez and Carrasco, 2003). Clearly, if
the SARS-CoV E protein forms such a helical hairpin under
the conditions of our bilayer experiments, both the N- and
C-termini would be located in the CIS chamber. From
energetic considerations, it would seem that incorporation of
a helical hairpin into lipid bilayers would be favored over
the alternative, which requires a large number of hydrophilic
amino acid residues to cross the bilayer into the TRANS
chamber. Unfortunately, an antibody was not available to us
with which to orient the C-terminus.
SARS-CoV E protein N-terminal first 40 amino acids
were sufficient for the formation of ion channels with
similar selectivity as the full-length E protein. Therefore, the
C-terminal of the SARS-CoV E protein is not essential for
ion channel conductance. It has also been shown that the
Vpu C-terminal hydrophilic domain does not participate in
ion channel conductance, and is not essential for regulation
of virus release, although the presence of the cytoplasmic
domain improves the function of Vpu, indicating that it may
have a regulatory role (Schubert et al., 1996a, 1996b).
Likewise, it is possible that the C-terminal of coronavirus E
proteins may have regulatory roles. Supporting this idea,
site-directed mutations to a cluster of charged amino acids in
the C-terminal of MHV E protein have been found to impair
viral assembly and maturation (Fischer et al., 1998).
SARS-CoV E protein ion channels have similar ion-
selectivity to previously described viral ion channels, Vpu,
NB, 6K, and p7, which also form cation-selective ion
channels in planar lipid bilayers (Ewart et al., 1996; Griffin
et al., 2003; Melton et al., 2002; Pavlovic et al., 2003; Piller
et al., 1996; Premkumar et al., 2004; Schubert et al., 1996a;
Sunstrom et al., 1996). Channels formed by Vpu and p7 are
equally selective for Na+ and K+ ions (Ewart et al., 1996;
Premkumar et al., 2004). The NB ion channel is selective
for Na+ at pH 5.5 to 6.5 (Sunstrom et al., 1996). The SARS-
CoV E protein is more selective for Na+ than for K+ ions,
and this has also been reported for 6K ion channels (Melton
et al., 2002). The SARS-CoV E protein is 90 times more
selective for Na+ than Cl ions, more selective than reported
for Vpu, 6K, or p7 ion channels (Ewart et al., 1996; Melton
et al., 2002; Premkumar et al., 2004).
The large range of conductance states observed with the
SARS E peptides have also been reported with other viral
ion channels (Ewart et al., 1996; Melton et al., 2002;
Premkumar et al., 2004; Sunstrom et al., 1996; Tosteson et
al., 1994). It is possible that the larger conductances are due
to opening of many clustered ion channels in the bilayer.Additionally, increased aggregation states of ion channels,
due to formation of homo-oligomeric complexes, can result
in variable ion conductances (Becker et al., 2004). Experi-
ments are underway to determine the homo-oligomeric state
of the SARS-CoV E protein.
The question of whether the ion channel activity of E
protein is involved in the known physiological roles of these
proteins in coronavirus replication remains to be investigated.
The best-characterized virus ion channels are the M2 channel
from influenza A and the Vpu ion channel from HIV-1. M2
ion channel activity has been linked to uncoating of the virion
in the early endosome (Mould et al., 2000) and mediating
transport of viral proteins through the excretory pathway
during viral assembly late in infection (Mould et al., 2000;
Sakaguchi et al., 1996). The hydrophobic N-terminal a-
helical domain of Vpu self-associates in membranes and
plays a part in the enhancement of budding and release of new
virus particles from infected cells (Klimkait et al., 1990)—an
activity that correlates with ion channel formation (Ewart et
al., 1996; Schubert et al., 1996a, 1996b).
The exact mechanism of Vpu-enhanced virus budding is
unknown (for review, see Montal, 2003). Evidence suggests
that Vpu plays a passive role in enhancement of viral
budding, perhaps through generalized affects on the cellular
environment, indirectly enhancing Gag trafficking to the
plasma membrane (Deora et al., 2000; Gottlinger et al., 1993;
Marassi et al., 1999; Montal, 2003; Schubert et al., 1996a).
Gottlinger et al. (1993) have shown that Vpu can significantly
enhance the release of Gag from heterologous retroviruses,
such as HIV-2, visna virus, and Moloney murine leukemia
virus, which do not normally express Vpu. Furthermore, Vpu
can partially compensate for a Sindbis 6K-deleted virus
(Gonzalez and Carrasco, 2001). Taken together, the data
suggests that Vpu does not directly interact with Gag during
virus budding (Gottlinger et al., 1993). Co-expression of Gag
and Vpu results in the redistribution of Gag from the cytosol
to the plasma membrane (Deora et al., 2000). In the absence
of Vpu, budding has been observed from internal membranes
(Klimkait et al., 1990).
Although Vpu does not directly interact with Gag, Vpu
has been shown to associate with cellular proteins (Geraghty
et al., 1994; Handley et al., 2001; Hsu et al., 2004). Recently,
it has been shown that Vpu shares homology with the N-
terminal domain of the mammalian background K+ channel,
TASK-1. Interaction of TASK-1 and Vpu results in Vpu
abolishing TASK-1 currents. Overexpression of TASK-1
impaired Vpu-enhanced viral budding; however, the N-
terminal domain of TASK-1 was able to enhance HIV-1
particle release (Hsu et al., 2004). Different levels of TASK-1
expression in various cell lines (Hsu et al., 2004) may explain
why Vpu viral enhancement is cell type dependent (Geraghty
et al., 1994; Gottlinger et al., 1991; Yao et al., 1992).
Furthermore, Vpu and Gag have been shown to bind to viral
protein U-binding Protein (Ubp) (Callahan et al., 1998;
Geraghty et al., 1994). Ubp may play a role in targeting Gag
to the plasma membrane (Handley et al., 2001).
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selectivity and both play a role in virus budding. E protein
has been shown to be important in coronavirus assembly
and morphogenesis (Bos et al., 1996; Fischer et al., 1998;
Kuo and Masters, 2003; Vennema et al., 1996). Conceiv-
ably, E protein ion channel could change the cellular milieu
at the budding site to enhance viral morphogenesis and
assembly. The scientific challenge remains to determine
how E protein ion channel activity mediates budding in the
coronavirus lifecycle.Materials and methods
Peptide synthesis and purification
A synthetic peptide corresponding to the full-length
SARS-CoV (isolate Tor2 and Urbani GenBank accession
number NC004718 and AY278741, respectively) E protein
(MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAIL-
TALRLCAYCCNIVNVSLVKPTVYVYSRVKNLNS-
SEGVPDLLV) and a second peptide corresponding to the
first 40 amino acids in the N-terminal transmembrane
domain of the E protein bN-terminal peptideQ (MYSFV-
SEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLC) were
synthesized on a SYMPHONY/MULTIPLEX (Protein
Technologies inc. Woburn, MS) multiple peptide synthe-
sizer, using FMOC chemistry and solid phase peptide
synthesis at the Biomolecular Research Facility, John Curtin
School of Medical Research following manufacturer’s
instructions.
To enrich the appropriate full-length product from the
crude synthesis reactions, the following procedure, relying
on the differential solubility of the smaller molecules and
full-length peptide, was devised. The crude preparation was
suspended at 12 mg/ml in 70% CH3CN, 0.1% TFA, and
vortexed for 10 min. This suspension was centrifuged at
10000  g for 10 min at 20 8C. The supernatant was
discarded and the insoluble fraction was further extracted
two more times with 70% CH3CN, 0.1% TFA, as above.
The insoluble material containing the E protein was dried in
a Speedvac and the weight of the final product was used to
calculate the yield. The purified peptides were analyzed by
Bruker Omniflex MALDI-TOF mass spectrometry in a
HABA matrix at 2.5 mg/ml in methanol at a 1:1 ratio and
spectra were obtained in the positive linear mode. A
predominant peak at m/z ratio of 8360.1 was seen, as was
expected for the calculated molecular weight of full-length
E protein. Similarly, a prevalent peak at 4422.3 m/z was
seen for the N-terminal peptide (see Fig. 1).
Raising and purifying antibodies against SARS-CoV E
protein
A synthetic peptide corresponding to SARS-CoV E pro-
tein N-terminal 19 residues (MYSFVSEETGTLIVNSVLC)was coupled to a polylysine core via the terminal cysteine
residue to prepare multiple antigenic peptides (MAP) (Lu et
al., 1991). Individual, crossbred New Zealand White rabbit
were immunized with the MAP peptides. Initial immuni-
zation was with 200 Ag of peptide in Freund’s complete
adjuvant (Imject, Pierce, Rockford, IL). Boosters of 200
Ag of peptide were given every 4 weeks in Freund’s
incomplete adjuvant (Imject, Pierce), until sufficient anti-
body titers were detected by Western blotting. About 15
ml of blood was collected by ear vein cannulation 2, 4, 6
and 8 weeks post-immunization and antisera prepared.
Antiserum was assayed for antibody production by west-
ern blotting with the SARS-CoV full-length purified
peptide. Specific antibodies were purified from antisera
by SulfoLink columns (Pierce) following manufacturer’s
instructions.
Western blots
For Western blots, samples were prepared in loading
buffer (60 mM Tris–HCl pH 8.3, 6 M urea, 5% SDS, 10%
glycerol, 0.2% bromophenol blue, F100 mM h-mercaptoe-
thanol) and run with molecular weight markers (MBI
Fermentas, Hanover, MD) on 4–20% gradient polyacryla-
mide gels (Gradipore, NSW, Australia). Peptides were
transferred to polyvinylidene difluoride membranes (Invi-
trogen, Vic, Australia), using a semidry transfer apparatus
(Amersham Biosciences, Vic, Australia). Nonspecific sites
were blocked with skim milk proteins in Tris-buffered saline
containing 1% Tween 20. Primary antibody was polyclonal
anti-N terminal (1:250), which was detected with goat anti-
rabbit IgG alkaline phosphatase-conjugated antibody (Dako,
NSW, Australia). Color development was detected with
Western Blue-stabilized substrate for alkaline phosphatase
(Promega, NSW).
Ion channel recording
The SARS-CoV full-length and N-terminal E protein were
resuspended at 1 mg/ml in 2,2,2-trifluoroethanol and their
ability to form ion channels was tested on aWarner bilayer rig
(Warner Instruments, Inc. 1125 Dixwell Avenue, Hamden,
CT 06514) as follows: A lipid mix of 3:1:1, 1-palmitoyl-2-
oleolyl phosphatidyl ethanolamine/1-palmitoyl-2-oleolyl
phosphatidyl serine/1-palmitoyl-2-oleolyl phosphatidyl chol-
ine in CHCl3 were dried under N2 gas and resuspended in n-
decane. Bilayers were painted across a circular hole of
approximately 100-Am diameter in a Delrin cup separating
aqueous solution in the CIS and TRANS chambers. For
testing E protein selectivity for Na+ and Cl ions, the solution
in the CIS chamber consisted of 500 mM NaCl and 5 mM
HEPES (pH 7.2), while the solution in the TRANS chamber
contained 50 mM NaCl and 5 mM HEPES (pH 7.2). For
testing E protein selectivity for K+ and Cl ions, the solution
in the CIS chamber consisted of 500 mM KCl, and 5 mM
HEPES (pH 7.2), while the solution in the TRANS chamber
L. Wilson et al. / Virology 330 (2004) 322–331330contained 50 mMKCl and 5mMHEPES (pH 7.2). Typically,
3 Ag of purified synthetic full-length or N-terminal E protein
was added to the CIS chamber while stirring until ion channel
activity was detected. The CIS chamber was earthed and the
TRANS chamber was held at various holding potentials
ranging between +100 to100 mV. Currents were amplified
using aWarner model BD-525D amplifier with sampling rate
of 5 kHz and filtered at 1 kHz before being digitally recorded
directly using the Data Collect software developed by Mr.
Bernie Keys (BioResearch Electronics, Canberra, Australia).
In some experiments in which ion channel activity was
detected, affinity-purified anti-N-terminal polyclonal anti-
body was added to the CIS or TRANS chamber to a final
concentration of about 10–20 Ag/ml, while stirring for 30 s.
A t test (SPSS Software, SPSS Inc. Chicago, IL) was used
to determine whether there was significant difference
between the mean current recorded before and after addition
of the antibody.Acknowledgments
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